Sir, The title of the paper by Dr Wieshammer and colleagues-"Limitations of radionuclide ventriculography in the non-invasive diagnosis of coronary artery disease" (1985; 53 :603-10)-deserves comment, lest it be taken to imply that radionuclide ventriculography is of limited use in the management of patients with coronary artery disease. For the title to have reflected all the findings of the study it would have been more reasonable to have omitted the words "radionuclide ventriculography in".
Sensitivity and specificity depend upon the population sampled, and the figures in this paper are not generally accepted experience because of the very low frequency (25%) of coronary artery disease in the patients studied. This letter was shown to the authors, who reply as follows:
Sir, In reply to Dr Underwood's comments we wish to re-emphasise that our study assessed the role of radionuclide ventriculography in the primary diagnosis of coronary disease only. We have neither stated nor implied that it is of limited value in the management of patients with established coronary disease but rather we share Dr Underwood's opinion about its usefulness in the latter setting. Each patient who was misdiagnosed by radionuclide ventriculography and referred for coronary bypass surgery had ischaemia at maximum exercise as shown by angina, ST depression, raised left ventricular filling pressure, or a combination of these indicators. The response of left ventricular ejection fraction to exercise was reported to be 53%-89% sensitive and 49%-100% specific for coronary disease. 1-3 Because of these wide ranges "generally accepted experience" is not easy to define. As we pointed out in our paper, the figures for sensitivity and specificity primarily depend upon the research design. We would like to focus on one methodological standard that is hardly ever adhered to in comparable studies. That is the avoidance of a posttest referral bias which occurs if the outcome of the exercise test influences a patient's likelihood of undergoing coronary angiography and thus of being included in the study. Preferential selection of positive test responders will increase the apparent disease frequency and will result in a falsely low specificity and falsely high sensitivity. To our knowledge there is no previous study on radionuclide ventriculography which meets this criterion and reports the number of eligible patients who refused to undergo coronary angiography and therefore had to be excluded. Adherence to this standard accounts for the low frequency of disease in our study group. 
